Kathryn Riley

1.8k total citations
30 papers, 1.2k citations indexed

About

Kathryn Riley is a scholar working on Psychiatry and Mental health, Physiology and Immunology. According to data from OpenAlex, Kathryn Riley has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Physiology and 6 papers in Immunology. Recurrent topics in Kathryn Riley's work include Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (5 papers) and Complement system in diseases (5 papers). Kathryn Riley is often cited by papers focused on Dementia and Cognitive Impairment Research (9 papers), Alzheimer's disease research and treatments (5 papers) and Complement system in diseases (5 papers). Kathryn Riley collaborates with scholars based in United States, United Kingdom and Canada. Kathryn Riley's co-authors include David A. Snowdon, William R. Markesbery, Mark Desrosiers, Charles D. Smith, Christine L. Tully, Suzanne L. Tyas, James A. Mortimer, Marta S. Mendiondo, Juan Carlos Salazar and R. J. Kryscio and has published in prestigious journals such as Blood, American Journal of Clinical Nutrition and Neurology.

In The Last Decade

Kathryn Riley

24 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathryn Riley United States 11 592 534 187 186 160 30 1.2k
Ming-Xin Tang United States 10 502 0.8× 543 1.0× 171 0.9× 158 0.8× 113 0.7× 10 1.2k
Ross Carne Australia 11 523 0.9× 274 0.5× 182 1.0× 191 1.0× 98 0.6× 18 1.2k
Yong Ji China 22 524 0.9× 587 1.1× 83 0.4× 86 0.5× 200 1.3× 70 1.6k
Stephen P. McIlroy United Kingdom 16 345 0.6× 404 0.8× 164 0.9× 69 0.4× 143 0.9× 20 1.0k
Anne Börjesson‐Hanson Sweden 22 477 0.8× 406 0.8× 65 0.3× 89 0.5× 204 1.3× 40 1.2k
Robert C. Green United States 24 909 1.5× 727 1.4× 66 0.4× 217 1.2× 141 0.9× 31 2.3k
Helena Chui United States 16 675 1.1× 517 1.0× 56 0.3× 155 0.8× 276 1.7× 20 1.5k
B. R. Reed United States 18 1.1k 1.8× 624 1.2× 162 0.9× 446 2.4× 344 2.1× 27 1.9k
Abdalla Bowirrat Israel 23 470 0.8× 311 0.6× 85 0.5× 263 1.4× 53 0.3× 98 1.5k

Countries citing papers authored by Kathryn Riley

Since Specialization
Citations

This map shows the geographic impact of Kathryn Riley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Riley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Riley more than expected).

Fields of papers citing papers by Kathryn Riley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Riley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Riley. The network helps show where Kathryn Riley may publish in the future.

Co-authorship network of co-authors of Kathryn Riley

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Riley. A scholar is included among the top collaborators of Kathryn Riley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Riley. Kathryn Riley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Michelle, Mark McMillan, Lynne Giles, et al.. (2025). The impact of obesity on influenza Vaccine immunogenicity: A systematic review. Vaccine. 65. 127794–127794.
2.
Tuckerman, Jane, Kathryn Riley, Sebastian Straube, et al.. (2023). Interventions for increasing the uptake of immunisations in healthcare workers: A systematic review. Vaccine. 41(38). 5499–5506.
3.
Hill, Anita, Morag Griffin, Talha Munir, et al.. (2019). Subcutaneous Alemtuzumab Has Activity in Treatment-Naïve Patients with Acquired Aplastic Anemia. Blood. 134(Supplement_1). 2503–2503.
4.
Griffin, Morag, Talha Munir, Peter Hillmen, et al.. (2017). Thrombosis in Non-Hemolytic Paroxysmal Nocturnal Haemogloinuria. Blood. 130. 1175–1175. 1 indexed citations
6.
Richards, Stephen J., Talha Munir, Morag Griffin, et al.. (2017). Extravascular Hemolysis Due to C3-Loading in Patients with PNH Treated with Eculizumab: Defining the Clinical Syndrome. Blood. 130. 3471–3471. 21 indexed citations
7.
Griffin, Morag, Austin Kulasekararaj, Shreyans Gandhi, et al.. (2016). Concurrent Treatment of Aplastic Anaemia (AA) with Immunosuppressive Therapy and Paroxysmal Nocturnal Hemoglobinuria (PNH) with Eculizumab: A UK Experience. Blood. 128(22). 2683–2683. 2 indexed citations
8.
Jicha, Gregory A., Erin L. Abner, Frederick A. Schmitt, et al.. (2011). Preclinical AD Workgroup staging: pathological correlates and potential challenges. Neurobiology of Aging. 33(3). 622.e1–622.e16. 51 indexed citations
9.
Riley, Kathryn, Gregory A. Jicha, Daron G. Davis, et al.. (2011). Prediction of Preclinical Alzheimer's Disease: Longitudinal Rates of Change in Cognition. Journal of Alzheimer s Disease. 25(4). 707–717. 36 indexed citations
10.
Tyas, Suzanne L., David A. Snowdon, Mark Desrosiers, Kathryn Riley, & William R. Markesbery. (2009). O2‐02‐01: Early‐life linguistic ability, late‐life pathology and asymptomatic Alzheimer's disease: Findings from the Nun Study. Alzheimer s & Dementia. 5(4S_Part_4).
11.
Tyas, Suzanne L., Juan Carlos Salazar, David A. Snowdon, et al.. (2007). Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study. American Journal of Epidemiology. 165(11). 1231–1238. 128 indexed citations
12.
Tyas, Suzanne L., David A. Snowdon, Mark Desrosiers, Kathryn Riley, & William R. Markesbery. (2007). Healthy ageing in the Nun Study: definition and neuropathologic correlates. Age and Ageing. 36(6). 650–655. 55 indexed citations
13.
Mortimer, James A., et al.. (2004). Delayed recall, hippocampal volume and Alzheimer neuropathology. Neurology. 62(3). 428–432. 69 indexed citations
14.
Riley, Kathryn, David A. Snowdon, Mark Desrosiers, & William R. Markesbery. (2004). Early life linguistic ability, late life cognitive function, and neuropathology: findings from the Nun Study. Neurobiology of Aging. 26(3). 341–347. 193 indexed citations
15.
Riley, Kathryn, David A. Snowdon, & William R. Markesbery. (2002). Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: Findings from the Nun Study. Annals of Neurology. 51(5). 567–577. 311 indexed citations
16.
Riley, Kathryn, David A. Snowdon, Ann M. Saunders, et al.. (2000). Cognitive Function and Apolipoprotein E in Very Old Adults. RePEc: Research Papers in Economics. 55(2). 69–75. 4 indexed citations
17.
Snowdon, David A., Christine L. Tully, Charles D. Smith, Kathryn Riley, & William R. Markesbery. (2000). Serum folate and the severity of atrophy of the neocortex in Alzheimer disease: findings from the Nun Study. American Journal of Clinical Nutrition. 71(4). 993–998. 215 indexed citations
18.
Riley, Kathryn, David A. Snowdon, Ann M. Saunders, et al.. (2000). Cognitive Function and Apolipoprotein E in Very Old Adults: Findings From the Nun Study. The Journals of Gerontology Series B. 55(2). S69–S75. 49 indexed citations
19.
Geddes, James W., David A. Snowdon, Tina L. Tekirian, et al.. (1996). BRAAK STAGES III-IV OF ALZHEIMER-RELATED NEUROPATHOLOGY ARE ASSOCIATED WITH MILD MEMORY LOSS, STAGES V-VI ARE ASSOCIATED WITH DEMENTIA. Journal of Neuropathology & Experimental Neurology. 55(5). 617–617. 8 indexed citations
20.
Kahana, Boaz, et al.. (1986). Motivators, resources and barriers in voluntary international migration of the elderly: The case of Israel-bound aged. Journal of Cross-Cultural Gerontology. 1(2). 191–208. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026